73°
Feels Like: 73°
53°
82°
62°
(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invali...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less mon...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Some people who received potentially contaminated steroid injections may benefit from...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scient...
Read More »By David Morgan WASHINGTON (Reuters) - Enroll America, a nonprofit group at the center of the political fight over President Barack ...
Read More »
By Ben Hirschler LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research ...
Read More »By Ransdell Pierson (Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after inject...
Read More »
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, al...
Read More »
By Kate Kelland LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to t...
Read More »
